• No results found

Inflammation and immunomodulation in uveal melanoma Ly, L.V.

N/A
N/A
Protected

Academic year: 2021

Share "Inflammation and immunomodulation in uveal melanoma Ly, L.V."

Copied!
11
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Inflammation and immunomodulation in uveal melanoma

Ly, L.V.

Citation

Ly, L. V. (2011, April 12). Inflammation and immunomodulation in uveal melanoma. Retrieved from https://hdl.handle.net/1887/16710

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/16710

Note: To cite this publication please use the final published version (if applicable).

(2)

INFLAMMATION AND IMMUNOMODULATION

IN UVEAL MELANOMA

(3)
(4)

INFLAMMATION AND IMMUNOMODULATION IN UVEAL MELANOMA

PROEFSCHRIFT ter verkrijging van

de graad van Doctor aan de Univeristeit Leiden,

op gezag van Rector Magnificus prof. mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op dinsdag 12 april 2011 klokke 16.15 uur

door Long Van Ly geboren te Dordrecht

in 1983

(5)
(6)

Promotiecommissie:

Promotor Prof. Dr. G.P.M. Luyten Co-promotores Dr. M.J. Jager

Dr. T. van Hall

Leescommissie Prof. Dr. S.M. Imhof (UMC Utrecht, Utrecht) Prof. Dr. R.E.M. Toes

Prof. K.C. McKenna, Ph.D. (University of Pittsburgh, Pittsburgh, PA, USA)

© L.V. Ly, 2011

ISBN: 978-90-816924-1-0

Druk: GVO drukkers & vormgevers BV/Ponsen & Looijen, Ede.

Niets uit deze uitgave mag verveelvoudigd en/of openbaar gemaakt worden zonder voorafgaande schriftelijke toestemming van de auteur. No part of this thesis may be reproduced in any form without written permission from the author.

Het onderzoek van dit proefschrift is gefinancierd door de Mozaiekbeurs (017.003.059) van De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Landelijke Stichting voor Blinden en Slechtzienden, Stichting Blinden-Penning, Leiden Universiteits Fonds, Gratama Stichting, Rotterdamse Stichting Blindenbelangen, Nelly Reef Fund, Nederlandse Vereniging voor Oncologie, Stichting Blindenhulp, Stichting Dondersfonds en Stichting Nederlands Oogheelkundig Onderzoek.

Het onderzoek beschreven in dit proefschrift werd uitgevoerd in het Leids Universitair Medisch Centrum op de afdeling oogheelkunde in samenwerking met de afdeling klinische oncologie.

(7)
(8)

Education is the great engine to personal development. It is through education that the daughter of a peasant can become a doctor, that the son of a mine worker can become the head of the mine, that the child of farm workers can become the president of a great nation. It is what we make of what we have, not what we are given, that separates one person from another.

Nelson Mandela.

To my father, from whom I inherited pragmatical thinking.

To my mother,

from whom I acquired diligence.

(9)
(10)

Contents

Chapter 1. Introduction

Chapter 2. Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?

Prog. Retin. Eye Res. 2011;30(2):129-46.

Chapter 3. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma

Invest. Ophthalmol. Vis. Sci. 2008;49(2):505-10.

Chapter 4. Detection of M2 macrophages in uveal melanoma and relation with survival

Invest. Ophthalmol. Vis. Sci. 2011;52(2):643-50.

Chapter 5. Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration

Invest. Ophthalmol. Vis. Sci. 2010;51(11):5445-51.

Chapter 6. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey

Invest. Ophthalmol. Vis. Sci. 2010;51(2):658-65.

Chapter 7. In aged mice, outgrowth of intraocular melanoma depends on pro-angiogenic M2-type macrophages

J. Immunol. 2010;185(6):3481-8.

Chapter 8. Peptide vaccination after T cell transfer causes massive clonal expansion, tumor eradication and manageable cytokine storm Cancer Res. 2010;70(21):8339-46.

Chapter 9. Peptide vaccination cooperates with tumor antigen-specific antibody for the treatment of established melanoma

Submitted article.

Chapter 10. Synopsis, discussion and future perspectives in English Chapter 11. Synopsis, discussion and future perspectives in Dutch

Acknowledgements (Dankwoord) Curriculum Vitae and List of publications

(11)

Referenties

GERELATEERDE DOCUMENTEN

CD11b+ macrophages have been attributed a role in T cell regulation, and McKenna and Kapp 59 showed that they are also involved in immune regulation against intraocular tumors

Conclusions: Monosomy 3 in uveal melanoma is associated with the presence of an inflammatory phenotype, consisting of a high HLA Class I and II expression as well

As M2-type macrophages are pro-angiogenic, the high density of especially these cells in uveal melanoma may contribute to the increased vascular density that was previously noticed

We determined the presence of 15 cytokines related to inflammation in 37 eyes with uveal melanoma, and compared the concentration of different cytokines to standard

Univariate cox analysis demonstrated that intravascular ingrowth of tumor cells had a hazard ratio (HR) of 2.01 (P < 0.01) for vessels inside the tumor, of 2.29 (P < 0.01)

(A) representative flow cytometry plots of peripheral blood of mice receiving T-cell receptor transgenic pmel T cells with or without vaccination with 20-mer long peptide

Blood samples of mice that were challenged with B16F10 tumors and treated with long peptide vaccines and TA99 antibody were taken five days after the second vaccination,

In Chapter 9, we demonstrate the effect of a monoclonal antibody (TA99), which acts on TRP-1, another antigen expressed on melanoma 12,13. We show that a 2